Arkema outlines cautious climate strategy, shares in Paris chemicals peer group

Arkema details its low?carbon roadmap and EU-linked climate targets while remaining a mid-cap player among European chemical stocks, with peers like BASF and Clariant also updating sustainability goals.

By Julia Schmitt, Sector & Peer Group desk. Reviewed prior to publication on 2026-06-25, 14:30.

Arkema (FR0010313833) uses its latest sustainability communication to sharpen its climate and energy profile. The specialty chemicals group, listed on Euronext Paris alongside peers like BASF and Clariant on other European exchanges, ties its roadmap closely to EU climate policy.

What Arkema reports on climate

Arkema sets a target to reduce absolute greenhouse gas emissions from its operations by a significant percentage by 2030 compared with a 2015 baseline, aligning its ambitions with the Paris Agreement and European Green Deal objectives, according to its investor relations materials.Arkema climate and sustainability presentations The group highlights investments in energy efficiency, process optimization and lower?carbon technologies across its production sites in France, the rest of Europe, North America and Asia.

In its sustainability reporting, Arkema describes increased use of renewable electricity and the progressive electrification of certain processes that were historically fossil-fuel based, with a focus on pilot projects and incremental capacity additions rather than sudden large-scale shifts.Arkema corporate news and sustainability updates The company references third?party frameworks such as the Science Based Targets initiative as benchmarks, although it emphasizes its own trajectory and sector-specific constraints.

Peer context in European chemicals

Within the broader European chemicals sector, Arkema positions itself as a specialty-focused player, numerically smaller than BASF or Covestro but with a mix of advanced materials and adhesives that benefit from structural trends such as lightweighting and energy-efficient construction. Sector reports from analysts regularly compare Arkema’s emissions intensity and capital allocation to peers including BASF, Clariant and Solvay.Reuters profile and sector comparison for Arkema These comparisons indicate that mid-cap specialty players often move faster on portfolio transformation than diversified commodity groups.

Analyst commentary on European chemicals periodically notes that sustainability metrics now feature explicitly in valuation discussions, with factors such as emissions trajectories, exposure to carbon pricing and alignment with circular-economy themes sharing space with traditional indicators like EBITDA margins and free cash flow.MarketScreener Arkema analyst consensus and sector notes Arkema’s climate roadmap, combined with its specialty portfolio skew, is therefore part of how brokers describe its longer-term equity story to clients.

The product behind the stock

Arkema generates revenue mainly from specialty materials used in demanding industrial and consumer applications. A representative product line is its high-performance polymers, such as polyamide and fluoropolymer families used in automotive, electronics, renewable energy and construction components where durability, chemical resistance and lightweight properties matter.

Where the stock trades today

The Arkema shares (FR0010313833) trade on Euronext Paris, with the latest price information and market capitalization data available from the exchange and financial data providers in euros at the most recent intraday quote.

Arkema at a glance

• Company: Arkema S.A.
• ISIN: FR0010313833
• WKN: A0BL7Z
• Ticker: AKE
• Trading venue: Euronext Paris
• Price (as of 2026-06-25, 12:00): latest quote in euros, intraday on Euronext Paris
• Market cap: latest reported market capitalization in euros (as of 2026-06-25)
• Sector / industry: Specialty Chemicals
• Index membership: SBF 120
• Next earnings date: not officially scheduled

This text is for informational purposes only and does not constitute investment advice, investment recommendation or an offer or solicitation to buy or sell any financial instrument. Figures, schedules and regulatory data are based on sources believed to be reliable but may change without notice.